Melanoma Clinical Trials in Texas

Showing 201-213 of 213 trials

High-Dose Interferon Alfa and Interleukin-2 in Treating Patients With Metastatic Kidney Cancer or Melanoma

NCT00003091

RATIONALE: Interferon alfa may interfere with the growth of cancer cells. Interleukin-2 may stimulate a person's white blood cells to kill kidney cancer or melanoma cells. PURPOSE: Phase II trial to study the effectiveness of high-dose interferon alfa and interleukin-2 in treating patients with metastatic kidney cancer or melanoma.

Kidney CancerMelanoma (Skin)

Hoag Memorial Hospital Presbyterian40 participantsStarted Jan 1996

Newport Beach, California, United States • Bloomington, Indiana, United States • Knoxville, Tennessee, United States +1 more locations

COMPLETEDPhase 3127 miles

CP-675,206 Versus Either Dacarbazine Or Temozolomide In Patients Without Prior Therapy

NCT00257205

This is a Phase 3, multi-national, open-label, 2-arm randomized study in patients with surgically incurable metastatic melanoma who have received no prior chemotherapy, or biochemotherapy for the treatment of metastatic disease. The primary objective of this trial is to compare overall survival for patients with advanced melanoma who are randomized to receive CP-675,206 with that of patients who are randomized to receive either dacarbazine or temozolomide (investigator choice)

Melanoma

AstraZeneca655 participantsStarted Mar 2006

Huntsville, Alabama, United States • Mobile, Alabama, United States • Scottsdale, Arizona, United States +140 more locations

PreviousPage 11 of 11

High-Dose Interferon Alfa and Interleukin-2 in Treating Patients With Metastatic Kidney Cancer or Melanoma

CP-675,206 Versus Either Dacarbazine Or Temozolomide In Patients Without Prior Therapy

Melanoma Trials in Other Cities

Trial of Dacarbazine With or Without Genasense in Advanced Melanoma

Study of XL281 in Adults With Solid Tumors

Study of Ipilimumab (MDX-010) Monotherapy in Patients With Previously Treated Unresectable Stage III or IV Melanoma

Randomized Trial of ATN-224 and Temozolomide in Advanced Melanoma

Vaccine Therapy for Patients With Stage IV Melanoma

CP-675,206 In Patients With Advanced Melanoma

Phase II Trial of Allovectin-7® for Metastatic Melanoma

SWOG-9430: Surgery in Treating Patients With Metastatic Melanoma

Study of CP-675,206 in Refractory Melanoma

Chemotherapy With or Without Immunotherapy in Treating Patients With Stage III or Stage IV Melanoma

Combination of Anti-CD137 & Ipilimumab in Patients With Melanoma

Other Conditions in Texas